| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 08/28/2013 | CN103266090A Asia1 type foot-and-mouth disease recombinant virus and preparation method and application thereof |
| 08/28/2013 | CN103265627A HPV16L1-g protein and coding gene and application thereof |
| 08/28/2013 | CN103265626A HPV16L1-f protein and coding gene and application thereof |
| 08/28/2013 | CN103265625A HPV16L1-h protein and coding gene and application thereof |
| 08/28/2013 | CN103263666A Duplex inactivated vaccine of porcine circovirus type 2 and porcine mycoplasma hyopneumoniae and preparation method of duplex inactivated vaccine |
| 08/28/2013 | CN102839158B Canine distemper attenuated vaccine strain and medical purpose |
| 08/28/2013 | CN102277367B Duck viral enteritis viral vaccine strain infective cloned system, its construction method and its application |
| 08/28/2013 | CN102114243B Method for preparing polyvalent vaccine of primary hamster kidney cells of flu |
| 08/27/2013 | US8519113 Bipartite system, method and composition for the constitutive and inducible expression of high levels of foreign proteins in plants |
| 08/27/2013 | US8518694 Nucleic acid vector comprising a promoter and a sequence encoding a polypeptide from the endogenous retrovirus PCAV |
| 08/27/2013 | US8518416 Compositions and methods for treatment of microbial infections |
| 08/27/2013 | CA2568015C Influenza hemagglutinin and neuraminidase variants |
| 08/27/2013 | CA2400441C Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereof |
| 08/22/2013 | WO2013121194A1 Materials and methods relating to packaging cell lines |
| 08/22/2013 | WO2013120529A1 New calicivirus |
| 08/22/2013 | US20130217095 Chimeric adenoviruses for use in cancer treatment |
| 08/21/2013 | CN103261411A Hepatitis c virus gene |
| 08/21/2013 | CN103255170A Oncolytic adenovirus construction method for targeted CD47 positive leukemia cells and application thereof |
| 08/21/2013 | CN103255163A EV71virus-like particles as well as preparation method and application thereof |
| 08/21/2013 | CN103255157A Infectious clone vector and application of genetype 7 hepatitis G virus gene |
| 08/21/2013 | CN103255137A Method for detecting SKA1 gene expression and purpose of siRNA thereof |
| 08/21/2013 | CN103255111A Green fluorescent protein marked recombinant swine fever virus,?its rescue method and application |
| 08/21/2013 | CN103255110A Methods of improving the introduction of DNA into bacterial cells |
| 08/21/2013 | CN103255102A Human embryonic lung fibroblast diploid cell line SLF-1 and applications thereof |
| 08/21/2013 | CN103254298A Plant-biological-yield related protein BrSTON1, and coding gene and applications thereof |
| 08/21/2013 | CN103254296A Protein AGGF1 and application of FHA polypeptide of protein AGGF1 in preparation of anti-inflammatory drug |
| 08/21/2013 | CN103251939A Candida albicans attenuated live vaccine as well as preparation method and application thereof |
| 08/21/2013 | CN102732486B Porcine circovirus type2 strain and application thereof |
| 08/21/2013 | CN102660511B Method for reducing pancreatin inhibitor in serum and application of serum |
| 08/21/2013 | CN102533679B Preparation of virus release buffer solution and application thereof |
| 08/21/2013 | CN102154325B Vaccine against human papillomavirus (HPV) as well as preparation method and application thereof |
| 08/20/2013 | US8512994 Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA |
| 08/20/2013 | US8512993 Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA |
| 08/20/2013 | US8512981 Vectors with modified initiation codon for the translation of AAV-Rep78 useful for production of AAV |
| 08/20/2013 | US8512713 Myxoma virus mutants for cancer treatment |
| 08/20/2013 | US8512712 Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions |
| 08/15/2013 | WO2013119285A1 Rare earth-containing filter block and method for making and using the same |
| 08/15/2013 | US20130210898 Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same |
| 08/15/2013 | US20130210135 Recombinant vsv for the treatment of tumor cells |
| 08/15/2013 | US20130209409 Chimeric adenoviruses for use in cancer treatment |
| 08/15/2013 | US20130209406 Recombinant rna viruses and uses thereof |
| 08/15/2013 | US20130209395 Nucleic acid molecule encoding hepatitis b virus core protein and surface antigen protein and vaccine comprising the same |
| 08/14/2013 | EP2626426A1 Hepatitis c virus gene |
| 08/14/2013 | EP2626078A1 Inoculation of recombinant viral vectors for rapid pre-exposure prevention and post-exposure protection against alphavirus-induced encephalitides |
| 08/14/2013 | EP2624864A2 Hemagglutinin polypeptides, and reagents and methods relating thereto |
| 08/14/2013 | CN103243067A Blood serum model and cell model of in vitro HBV (Hepatitis B Virus) infection and building method thereof |
| 08/14/2013 | CN103242438A Two types of plant proteins as well as coding genes and application thereof |
| 08/14/2013 | CN102671194B Human vaccine for preventing hydrophobia and tetanus |
| 08/14/2013 | CN102586194B H9 subtype avian influenza virus Vero cell adapted strain and application thereof |
| 08/14/2013 | CN102533673B Chicken infectious bursal disease very virulent cell adapted strain and application thereof |
| 08/14/2013 | CN102344912B Porcine pseudorabies virus strain and porcine pseudorabies inactivated vaccine prepared by using same |
| 08/14/2013 | CN101965396B Recombinant vaccinia virus having hepatitis c virus gene |
| 08/14/2013 | CN101952320B Material with immunogenicity |
| 08/14/2013 | CN101869702B Vaccine produced by suspended microcarrier cell culture system and method for producing vaccine |
| 08/14/2013 | CN101711278B T4 bacteriophage bound to a substrate |
| 08/14/2013 | CN101688188B Method for purifying a viral suspension |
| 08/14/2013 | CN101128478B N protein mutants of porcine reproductive and respiratory syndrome virus |
| 08/13/2013 | US8507267 AAV4 vector and uses thereof |
| 08/13/2013 | US8507247 Influenza A virus with attenuating mutations in NS2 protein |
| 08/13/2013 | US8506968 SARS vaccine compositions and methods of making and using them |
| 08/13/2013 | CA2529647C Influenza hemagglutinin and neuraminidase variants |
| 08/13/2013 | CA2464138C Methods of preventing and treating flavivirus infection in animals |
| 08/13/2013 | CA2304932C Recombinant rsv virus expression systems and vaccines |
| 08/08/2013 | WO2013116778A2 Immunogenic adenovirus |
| 08/08/2013 | WO2013116591A1 Adenoviral vector-based malaria vaccine |
| 08/08/2013 | US20130203152 Method for Reducing DNA Impurities in Viral Compositions |
| 08/08/2013 | US20130203151 Production of alphavirus replicon particles in packaging cells |
| 08/08/2013 | US20130202639 Synthetic Herpes Simplex Viruses for Treatment of Cancers |
| 08/08/2013 | US20130202559 Use of Microvesicles in the Treatment of Medical Conditions |
| 08/07/2013 | EP2622067A1 Method for separating off viruses from a liquid medium containing contaminants |
| 08/07/2013 | CN103237890A Novel method for generation of RNA virus |
| 08/07/2013 | CN103237889A Adenoviral assembly method |
| 08/07/2013 | CN103232976A Medium supplement for virus production |
| 08/07/2013 | CN103232535A Protein ZmVDE relevant to sugarcane mosaic virus infected maize as well as coding gene and application of protein thereof |
| 08/07/2013 | CN103232381A Peptidomimetic protease inhibitors |
| 08/07/2013 | CN102552898B Purification preparation method of human rotavirus inactivated vaccines by utilizing ion exchange chromatography |
| 08/07/2013 | CN102443594B Receptor activator of nuclear factor kappa B ligand (RANKL)-HBaAg expression constructing object, yeast, manufacture method as well as application |
| 08/07/2013 | CN102178948B Genetic engineering drug for treating and/or preventing cervical cancer |
| 08/07/2013 | CN101979518B Method for preparing pseudorabies virus |
| 08/07/2013 | CN101386606B 3-amino-7-dialkylamide substituted phenothiazines compounds and preparation method and use thereof |
| 08/06/2013 | US8501453 Methods for drying bacteriophage and bacteriophage-containing compositions, the resulting dry compositions, and methods of use |
| 08/06/2013 | CA2388807C Viruses for the treatment of cellular proliferative disorders |
| 08/06/2013 | CA2358385C Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 08/01/2013 | WO2013112780A1 Methods for increasing the infectivity of viruses |
| 08/01/2013 | WO2013112778A1 Methods for increasing the infectivity of viruses |
| 08/01/2013 | WO2013059168A3 Espirito santo virus and methods for detecting and preventing infection with the same |
| 08/01/2013 | US20130195918 Equine Herpesvirus 1 Vaccine and Vector and Uses Thereof |
| 08/01/2013 | US20130195915 Influenza C Virus and Vaccine |
| 07/31/2013 | EP2618841A1 Bvdv vaccine |
| 07/31/2013 | EP2618839A1 Methods to produce bunyavirus replicon particles |
| 07/31/2013 | CN1989240B Vaccine comprising an attenuated pestivirus |
| 07/31/2013 | CN103228790A Stable production of lentiviral vectors |
| 07/31/2013 | CN103228271A Anti-viral azide containing compounds |
| 07/31/2013 | CN103224914A Construction and application of recombinant peste des petits ruminants virus expressing fused exogenous epitope N protein |
| 07/31/2013 | CN103224913A Duck plague live vaccine and preparation method thereof |
| 07/31/2013 | CN103224911A Porcine retina cell and application thereof |
| 07/31/2013 | CN103224554A Ciliate desert-grass arsenium channel protein PvAQP1, and coding gene and application thereof |
| 07/31/2013 | CN102586198B Recombinant adenovirus capable of resisting foot and mouth disease virus replication and infection as well as preparation method and application of recombinant adenovirus |
| 07/31/2013 | CN102260650B Large-scale production method of fowl Marek's disease virus |
| 07/31/2013 | CN102221618B Method for establishing hog cholera lapinized virus labeled vaccine strain and preparing vaccine |